State of New Jersey Common Pension Fund D Has $1.84 Million Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

State of New Jersey Common Pension Fund D trimmed its position in Amedisys, Inc. (NASDAQ:AMEDFree Report) by 32.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,018 shares of the health services provider’s stock after selling 9,583 shares during the quarter. State of New Jersey Common Pension Fund D owned approximately 0.06% of Amedisys worth $1,838,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Eubel Brady & Suttman Asset Management Inc. raised its stake in shares of Amedisys by 66.4% during the second quarter. Eubel Brady & Suttman Asset Management Inc. now owns 8,439 shares of the health services provider’s stock worth $775,000 after buying an additional 3,368 shares during the last quarter. Quest Partners LLC lifted its stake in shares of Amedisys by 109.9% in the 2nd quarter. Quest Partners LLC now owns 7,338 shares of the health services provider’s stock valued at $674,000 after purchasing an additional 3,842 shares during the period. Trium Capital LLP bought a new position in shares of Amedisys in the 2nd quarter worth $339,000. Arizona State Retirement System grew its stake in shares of Amedisys by 2.0% during the second quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock worth $840,000 after purchasing an additional 177 shares during the period. Finally, Privium Fund Management UK Ltd bought a new stake in Amedisys in the second quarter valued at about $1,284,000. 94.36% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AMED. William Blair cut Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Cantor Fitzgerald restated a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price for the company. in a research note on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $100.67.

Check Out Our Latest Stock Report on AMED

Amedisys Trading Down 0.4 %

NASDAQ:AMED opened at $96.87 on Tuesday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The business’s 50-day simple moving average is $97.67 and its 200-day simple moving average is $94.87. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $98.95. The stock has a market capitalization of $3.17 billion, a PE ratio of -151.36, a price-to-earnings-growth ratio of 1.89 and a beta of 0.78.

Amedisys (NASDAQ:AMEDGet Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.10. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The firm had revenue of $591.19 million for the quarter, compared to analyst estimates of $579.34 million. Sell-side analysts expect that Amedisys, Inc. will post 4.66 earnings per share for the current fiscal year.

Amedisys Company Profile

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Articles

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMEDFree Report).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.